PETMED EXPRESS INC — Form 8-K
Filed September 17, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 62/100
What the filing says
PetMed Express appointed Jeff Willard as CEO and President effective September 28, 2026, replacing interim CEO Leslie C.G. Campbell who is retiring from the Board. Willard receives a $550,000 base salary, $120,000 signing bonus, 75% target annual bonus (up to 150% max), initial equity grant of 250,000 restricted shares plus up to 250,000 performance stock units, and $750,000 annual long-term incentive target. Severance varies: 12 months base salary outside change-of-control window, 24 months within 12 months post-acquisition, plus benefits. Board Chair Justin Mennen succeeds Campbell effective same date.
Why this rating
CEO transition is significant for $46M company but Willard's hire appears stabilizing after interim period. Compensation (~$1.7M first-year all-in) is ~3.7% of market cap—material but not transformational. No strategic deal announced; execution risk remains high.
See more from September 17, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.